Skip to content

Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes

Death rate in Malawi falls by up to 35% due to free HIV treatment

HIV, but not HHV-8, found to increase risk of pulmonary arterial hypertension

Circumcision and partner reduction should be priorities for HIV prevention, say US researchers

Does tenofovir increase the risk of efavirenz-associated liver side-effects?

HIV reduces body's ability to control hepatitis C replication

Nearly all patients with NNRTI resistance could benefit from etravirine, UK analysis shows

BHIVA: Many patients and clinicians still need educating about the benefits of treatment

Insulin resistance may predict risk of cardiovascular disease in HIV